Interim Report 2017-01-01 – 2017-09-30
The Board and CEO of Oncology Venture Sweden AB hereby announce the interim report for the first three quarters of 2017. “Oncology Venture Sweden AB” refers to Oncology Venture Sweden AB, organisation no 559016-3290. “The company”, or “Oncology Venture” refers to the business group, i.e. Oncology Venture Sweden AB and subsidiaries Oncology Venture ApS (100% ownership), 2X Oncology (92 % ownership) and OV-SPV2 ApS (40 % ownership). Summary of Interim Report The First Nine Months (2017-01-01 – 2017-09-30) · Net sales: 2 091 KSEK (2 647 KSEK) · Profits after tax: -34 020 KSEK (